Primary melanoma tumors from CDKN2A mutation carriers do not belong to a distinct molecular subclass

J Invest Dermatol. 2014 Dec;134(12):3000-3003. doi: 10.1038/jid.2014.272. Epub 2014 Jul 7.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Australia
  • Case-Control Studies
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics*
  • Europe
  • Female
  • GTP Phosphohydrolases / genetics
  • Gene Expression Profiling
  • Heterozygote*
  • Humans
  • Male
  • Melanoma / classification*
  • Melanoma / genetics*
  • Membrane Proteins / genetics
  • Middle Aged
  • Mutation / genetics*
  • Nevus / classification
  • Nevus / genetics
  • Phenotype
  • Proto-Oncogene Proteins B-raf / genetics
  • Skin Neoplasms / classification*
  • Skin Neoplasms / genetics*
  • Young Adult

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • Membrane Proteins
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • GTP Phosphohydrolases
  • NRAS protein, human